Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study.
Eur Psychiatry. 2017 Sep;45:97-103. doi: 10.1016/j.eurpsy.2017.05.022. Epub 2017 Jun 12.
Eur Psychiatry. 2017.
PMID: 28753464
Free article.
Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary.
Takács P, Czobor P, Fehér L, Gimesi-Országh J, Fadgyas-Freyler P, Bacskai M, Rakonczai P, Borsi A, Hegyi R, Németh T, Sermon J, Bitter I.
Takács P, et al. Among authors: rakonczai p.
PLoS One. 2019 Jun 13;14(6):e0218071. doi: 10.1371/journal.pone.0218071. eCollection 2019.
PLoS One. 2019.
PMID: 31194778
Free PMC article.
Item in Clipboard
Long-term drug survival and predictor analysis of the whole psoriatic patient population on biological therapy in Hungary.
Pogácsás L, Borsi A, Takács P, Remenyik É, Kemény L, Kárpáti S, Holló P, Wikonkál N, Gyulai R, Károlyi Z, Rakonczai P, Balázs T, Szegedi A.
Pogácsás L, et al. Among authors: rakonczai p.
J Dermatolog Treat. 2017 Nov;28(7):635-641. doi: 10.1080/09546634.2017.1329504. Epub 2017 Aug 9.
J Dermatolog Treat. 2017.
PMID: 28789582
Item in Clipboard
Modelling Dependence Between Disability Status and Health Service Costs of People With Rheumatoid Arthritis in Hungary.
Rakonczai P, Nagy B, Rojkovich B, Gáti T.
Rakonczai P, et al.
Value Health. 2014 Nov;17(7):A551. doi: 10.1016/j.jval.2014.08.1797. Epub 2014 Oct 26.
Value Health. 2014.
PMID: 27201795
Free article.
No abstract available.
Item in Clipboard
Cost-Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States.
Reifsnider OS, Tafazzoli A, Linden S, Ishak J, Rakonczai P, Stargardter M, Kuti E.
Reifsnider OS, et al. Among authors: rakonczai p.
J Am Heart Assoc. 2024 Feb 20;13(4):e029042. doi: 10.1161/JAHA.123.029042. Epub 2024 Feb 16.
J Am Heart Assoc. 2024.
PMID: 38362909
Free PMC article.
Item in Clipboard
Cost-effectiveness analysis of empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-Reduced trial.
Tsutsui H, Sakamaki H, Momomura SI, Sakata Y, Kotobuki Y, Linden S, Reifsnider OS, Rakonczai P, Stargardter M, Murata T, Hirase T, Nitta D.
Tsutsui H, et al. Among authors: rakonczai p.
J Cardiol. 2023 Jun;81(6):522-530. doi: 10.1016/j.jjcc.2023.02.007. Epub 2023 Feb 28.
J Cardiol. 2023.
PMID: 36858174
Free article.
Item in Clipboard
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction.
Tafazzoli A, Reifsnider OS, Bellanca L, Ishak J, Carrasco M, Rakonczai P, Stargardter M, Linden S.
Tafazzoli A, et al. Among authors: rakonczai p.
Eur J Health Econ. 2023 Dec;24(9):1441-1454. doi: 10.1007/s10198-022-01555-6. Epub 2022 Dec 4.
Eur J Health Econ. 2023.
PMID: 36463524
Free PMC article.
Item in Clipboard
Cite
Cite